XX Chromosome Dosage Boosts Mitochondrial Antioxidant Capacity in Cholinergic Neurons, Shielding NGF Transport from Age‑Related Oxidative Failure

Hypothesis

XX karyotype confers cholinergic resilience by elevating dosage of X‑linked escape genes that encode mitochondrial antioxidant proteins, thereby reducing oxidative inhibition of TrkA‑mediated NGF retrograde transport.

Mechanistic Basis

Aging cholinergic basal forebrain neurons suffer oxidative/nitrative stress that impairs TrkA signaling and leads to cortical NGF accumulation and forebrain depletion [4]. Escape from X‑inactivation affects 15‑25 % of X‑linked loci, many of which encode enzymes such as SOD2, GPX4, and peroxiredoxins that detoxify mitochondrial ROS. In XX cells, biallelic expression of these genes yields higher antioxidant capacity than in XY cells, where only a single allele is active. This dosage effect can preserve TrkA phosphorylation and downstream PI3K‑Akt signaling, maintaining cholinergic tone and limiting amyloid‑beta‑driven pathology [1]. Notably, females display higher frontal cortex cholinergic activity while males show greater hippocampal activity [2], a pattern that could stem from regional differences in mitochondrial ROS handling driven by X‑gene dosage.

Experimental Design

Utilize the Four Core Genotypes (FCG) mouse model to dissociate sex chromosomes from gonads. Generate four groups: XX‑F, XX‑M, XY‑F, XY‑M (where letters denote gonadal sex). At 12 months, assess:

• ChAT‑immunopositive neuron counts in the medial septum and vertical limb of the diagonal band [3]
• NGF retrograde transport efficiency via fluorescent NGF tracer accumulation in cortex versus basal forebrain
• Mitochondrial ROS levels (MitoSOX) and antioxidant enzyme activity (SOD2, GPX4) in isolated cholinergic neurons
• TrkA phosphorylation (p‑TrkA) and downstream Akt signaling Parallelly, employ AAV‑mediated shRNA to knock down a candidate escape gene (e.g., Sod2) specifically in cholinergic neurons of XX‑F mice to test necessity.

Expected Outcomes

If the hypothesis is correct, XX‑F and XX‑M mice will show:

• Higher ChAT+ neuron density than XY counterparts, independent of gonadal sex.
• Enhanced NGF transport (lower cortical/hippocampal NGF, higher basal forebrain NGF)
• Reduced mitochondrial ROS and elevated SOD2/GPX4 activity
• Increased p‑TrkA/Akt signaling Knockdown of Sod2 in XX‑F mice should abolish these advantages, bringing phenotypes down to XY levels. Conversely, overexpressing Sod2 in XY‑M mice should rescue cholinergic markers. Failure to observe XX‑linked differences, or lack of rescue by antioxidant manipulation, would falsify the hypothesis.

Implications

Positioning the X chromosome as a longevity determinant shifts focus from hormonal modulation to intrinsic gene dosage mechanisms. It predicts that therapeutic upregulation of X‑linked mitochondrial antioxidants could mitigate cholinergic decline in both sexes, offering a sex‑agnostic strategy for Alzheimer’s prevention.